PhoreMost has published new data validating its GlueSEEKER platform, a high-throughput technology designed to accelerate ...

Small molecule drugs are low-molecular-weight, organic compounds used to treat a wide range of conditions. Here's what you should know.

In the battle against aggressive breast cancer, a once-elusive target is now within reach—thanks to a breakthrough from a ...

Scientists have uncovered a molecular "on–off" switch that helps lung adenocarcinoma—the most common form of lung cancer—grow ...

PhoreMost Ltd., a next-generation targeted protein degradation (TPD) company progressing a pipeline of degrader therapeutics ...

In a major stride toward tackling aggressive breast cancer, researchers from The Hebrew University of Jerusalem have developed druglike molecules that degrade a previously "undruggable" cancer-driving ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, and the A*STAR Genome Institute of Singapore ...

Both lead authors for the study state "extraordinary claims require extraordinary evidence" as they await for trial results.

An 'extraordinary' new class of drugs are set to undergo human trials after researchers believe they could become the first ...

Elix is a Japan-based AI drug discovery company with a mission to "Rethinking drug discovery," providing services to ...

In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting ...